Oral Oncology

Article	Citations
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma	351
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model	98
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis	75
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review	55
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?	51
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma	51
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study	50
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review	47
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients	47
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2	39
Editorial Board/Aims & Scope	36
P28 Head and neck cancer cells differentiate resembling their tissue of origin	35
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders	34
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies	32
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]	32
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)	31
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment	31
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”	31
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study	30
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database	29
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis	29
Radiation-induced sarcomas of the craniofacial region: A systematic review	28
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection	28
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions	28
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection	28

Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection	27
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker	27
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma	27
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies	27
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study	27
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]	27
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma	26
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”	26
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”	26
Commentary on, “Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.”	26
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis	26
Commentary on, “Optimization of methylation capture sequencing workflow in formalin fixed tissue from oral squamous cell carcinoma patients”	26
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”	25
What does margin mean in laryngeal surgery?	24
Comment on: Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1–2, N0) oral cavity squamous cell carcinoma: A matched pair analysis	24
Required time for pre-oncological dental management – A rapid review of the literature	24
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples	24
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study	24
Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation	23
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis	23
Overestimated risk of transformation in oral lichen planus	22
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer	22
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study	21
Artificial intelligence for oral cancer diagnosis: What are the possibilities?	21
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer	20
Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990–2021	20
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study	20
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes	20
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis	20
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials	19
Comment on “The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis”	19
Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma	19
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers	19
Selective autophagy as a potential therapeutic target for oral cancer	19
Osteoblastoma of the maxilla: A case report and review of the literature	19
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge	19
Elective neck dissection: Are we bound to outdated concepts?	19
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients	19
Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions	19
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients	19
Innovative applications of hybrid operating room in otolaryngology: A pilot study	19
Pain management with popliteal block for fibular graft harvesting in head and neck reconstruction; a randomised double-blind placebo-controlled study	18
Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI	18
Commentary on: From mutation maps to clinical impact: Unraveling OSCC genomics in a japanese nationwide cohort	18
Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors	18
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial	18
Commentary on, “Margin analysis of radical tonsillectomy specimens following transoral robotic surgery”	18
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer	18
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity	18
Impact of HPV status on immune responses in head and neck squamous cell carcinoma	18

O1.3 Awareness of HPV-associated oropharyngeal cancer among the general population and general practitioners in the Netherlands: Cross-sectional study	18
Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis:	18
Tobacco induced epithelial dysplasia at minor salivary gland excretory duct and oral cancer	17
Corrigendum to “Prognostic factors in surgically treated malignant salivary gland tumors” [Oral Oncol. 144 (2023) 106484]	17
Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?	17
Editorial Board	17
FLASH radiotherapy in head and neck cancer: Myth or reality?	17
P25 The role of ultrasound elastography for clinical neck staging in HPV-related oropharyngeal cancer	17
“In response to “Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia”	17
Completion thyroidectomy for intermediate risk factors after thyroid lobectomy	17
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma	16
Association between E-cigarette use and oral HPV-16 infection	16
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma	16
The importance of early treatment of oral squamous cell carcinoma: Case report	16
Papillary thyroid cancer in black thyroid: A case report	16
P35 Spatial proteomics and metabolomics investigations in head & neck cancers	16
P29 Comparison of selected clinical factors and treatment results according to HPV status in patients with oropharyngeal cancer treated with radiotherapy alone or combined with chemotherapy	16
Comment on “The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study”	16
Letter to the Editor: Prognostic value of age-adjusted comorbidity scoring in OSCC - a step toward personalized oncology	16
Editorial Board/Aims & Scope	16
Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions	16
Corrigendum to “Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas”. [Oral Oncol. 163 (2025) 107207]	16
Validity of functional patient-reported outcomes in head and neck oncology: A systematic review	15
“Time is not to be wasted”	15
Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas	15
Positive margins matter regardless of subsequent resection findings	15
Letter to Editor on, “De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study”	15
Response to the comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”	15
Comparison between adult comorbidity evaluation-27 and Charlson Comorbidity Index in head and neck oncology	15
ChatGPT: Empowering dentistry with future possibilities	15
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy	15
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis	15
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma	15
Primary intraosseous malignant peripheral nerve sheath tumor of the mandible: An unusual presentation mimicking a benign lesion	15
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?	15
Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones	15
Re-evaluating Lymph Node Yield, Lymph Node Ratio, and the number of metastatic nodes as prognostic factors in oral cavity squamous cell carcinoma	15
Clinical value of entire-circumferential intraoperative frozen section analysis for the complete resection of superficial squamous cell carcinoma of the tongue	14
Ferroptosis: An emerging therapeutic target for oral cancer	14
The case against lingual mucosectomy	14
Comment on, “Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes”	14
Two-stage surgery for the treatment of nonmelanoma skin cancer of the face: Change of surgical strategy during COVID-19 pandemic	14
Lymph node yield and ratio in the central compartment	14
Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer	14
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma	14
Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma	14
Covid-19 pandemic and head and neck cancers, what should we expect?	14
Palliative care utilization among head and neck cancer patients: A population-based analysis	14
Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal c	14
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study	14
Editorial Board	14
A rare case of extranodal Rosai Dorfman disease of zygoma	14
Correspondence on “Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040”	14
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma – “Need for incorporation of sub classification of pT4b lesions”	14
Unfamiliar case of metastatic myxoid leiomyosarcoma of mandible	14
Extent of neck dissection in the N+ neck: Adjudicating a Conundrum!	14
Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma	14
Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis	14
Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor	14
The submandibular gland in neck dissection: A necessary casualty or a hapless victim?	14
O3.3 Proximity ligation-based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas	14
Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case	14
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)	13
Confusion prevails in severe oral epithelial dysplasia with microinvasion versus microinvasive carcinoma	13
Comment on “Surgical, functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review”	13
Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma	13
Letter to the editor, “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer”	13
Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery	13
Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma	13
Hemangiomatous adenomatoid odontogenic tumor of maxilla: A new variant?	13
Late oral adverse effects of chemotherapy for hematological malignancies in children: A systematic review and meta-analysis of case-control studies	13
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer	13
Metformin and oral cancer	13
Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?	13
Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy	13
Comment on: Life following total laryngectomy: mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort	12
CD271high cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma	12
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening	12
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?	12
The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma	12

Mitigating survival disparities in head and neck cancer: urgent need to reduce ED-based biopsy delays	12
Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma	12
The integration of female physiological and social role factors in HRQOL research	12
CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy	12
Critical appraisal of post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA: promising potential amid methodological c	12
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery	12
Superficial angiomyxoma affecting the buccal mucosa: A detailed immunohistochemical study and literature review	12
Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial	12
Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma	12
Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study	12
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck	12
Revolutionizing HPV-driven cancer surveillance: A commentary on the validation of the HPV-SEQ liquid biopsy platform	12
Corrigendum to “Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma” [Oral Oncol. 134 (2022) 106131]	11
Role of neoadjuvant chemotherapy in head and neck cancer management: A case for exploring diverse treatment strategies for evaluating long-term efficacy	11
Thyroid volumes after intensity‐modulated radiotherapy as predictors of radiation‐induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study	11
Should sitting time be a treatment target in head and neck cancer patients receiving curative treatment?	11
Mammary analogue secretory carcinoma presenting as localized hematoma of the palate	11
Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells – Multifunctional therapeutic approach against oral cancer	11
O3.2 Loss of LRP1B expression drives chemo and radiation resistance in HPV-positive head and neck cancer	11
Tongue cancer in non-smoking and non-alcoholic mother and daughter	11
EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer	11
Perioral reconstruction by submental flap	11
E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma	11
Comment on: Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy	11
Commentary on “Predictive value of CXCL1+_FAP+ phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients”	11
Pain management following transoral robotic surgery for oropharyngeal squamous cell Carcinoma: A systematic review	11
Corrigendum to “Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer” [Oral Oncol. 51 (2015) 565–569]	11
The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations	11
O1.2 Single cell RNA sequencing allows mapping of HPV transcripts in head and neck cancer epithelial cells	11
Analysis of the effects of mandibular reconstruction based on microvascular free flaps after oncological resections in 21 patients, using 3D planning, surgical templates and individual implants	11
Comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”	11
Corrigendum to “Flash radiotherapy-gateway to promised land or another mirage” [Oral Oncol. 139 (2023) 106342]	11
Editorial Board	11
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unre	11
Editorial Board/Aims & Scope	11
Merkel cell carcinoma – Time to consider personalized medicine and combinatorial therapeutic strategies	11
Lichenoid infiltrate in oral submucous fibrosis: A new marker of malignant transformation	11
Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study	10
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer	10
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-	10
The impact of physician’s characteristics on decision-making in head and neck oncology: Results of a national survey	10
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area	10
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma	10
Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequentia	10
Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan	10
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 s	10
Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis	10
Letter to the Editor: “Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma”	10
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation	10
Secretory carcinoma ex pleomorphic adenoma of the submandibular gland: An immunohistochemical study	10
Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer	10
The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer	10
Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck	10
The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring	10
Toward comprehensive optimization of larynx-preserving strategies in MI-LSCC	10
Anti-epidermal growth factor receptor targeted therapy-associated ulcerations	10
Telescreening as an alternate modality for early detection of oral cancer	10
When histology tells a different story: salivary duct carcinoma in disguise	10
Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments	10
Letter to the editor “The use of 3D computer-aided design to optimize photoimmunotherapy catheter placement”	10
Correlation between radiological, macroscopic and microscopic depth of invasion in oral squamous cell carcinoma: A prospective study using contrast-enhanced computed tomography	10
Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: RestorabiteTM	10
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study	10
Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice	10
Spindle cell carcinoma of the lip: An immunohistochemical study of a challenging case	9
AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas	9
Authors reply to comment by Irene Lafuente-Ibáñez de Mendoza and Aguirre-Urizar JM	9
Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis	9
Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla	9
A rare case of Merkel cell carcinoma on the craniofacial region and characterization of its aneuploid CD31− CTCs and CD31+ CTECs expressing EpCAM or Ki-67	9
Corrigendum to “Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer” [Oral On	9
Establishing a role for the oral microbiome in infectious complications following major oral cavity cancer surgery	9
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens	9
Commentary on “Predicting reactive Gastrostomy-Tube placement after head and neck free flap Reconstruction”	9
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study	9
Mucosal resurfacing of the suprastructure maxillectomy cavity using nasal cavity mucosa flaps	9
In regard to Riddhima Agarwal et al	9
Trans-cervical mandibulotomy approach for a multi-compartmental trigeminal Schwannoma: A surgeon’s guide	9
Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer pat	9
Personalized intraoral devices in the era of high-technology head and neck radiotherapy: A resource to be explored	9
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma	9
Lung cancer metastases to the oral cavity: Report of two cases and review of literature	9
Right colonic interposition for severe pharyngoesophageal stricture in head and neck patients: A feasible rescue strategy after multiple failed reconstructive options	9
Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer	9
Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores	9
Genetic characteristics of a highly metastatic basal cell adenocarcinoma arising in buccal mucosa	9
Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature	9
Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: Controversies and contemporary perspectives	9
Editorial Board/Aims & Scope	9
Young non-smokers with oral cancer: What are we missing and why?	9
Prognostic factors in surgically treated malignant salivary gland tumors	9
Commentary on, “Oncologic significance of the lateral margin in buccal cancer.”	9
Rapid physical and emotional palliation from QUAD shot radiotherapy to a frail elderly patient with stage IV parotid gland cancer-associated facial paralysis and pain when no other palliative interven	8
O2.3 Detection and monitoring of circulating tumor HPV DNA in HPV-associated sinonasal and nasopharyngeal cancers	8
P05 Study of viral Biomarkers and MicroRNAs in HPV-associated Oropharyngeal cancer and cancer of unknown primary	8